Rukiye Arıkan

10PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 17, 2025
Prognostic value of psoas muscle index in metastatic renal cell carcinoma patients treated with anti-VEGF therapy.

Rukiye Arıkan, Özlem Demircioğlu, Salih Özgüven

|Dec 30, 2024
Evaluating the performance of the MSKCC gastric cancer survival calculator in the Turkish population.

İlknur Deliktaş Onur, Tuğba Başoğlu, Nazım Can Demircan

|Mar 02, 2023
Prognostic value of Gustave Roussy immune score in operable pancreatic adenocarcinoma.

Tugba Basoglu, Nalan A Babacan, Fatih E Ozturk

|Nov 30, 2022
Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters.

Rukiye Arikan, Salih Ozguven, Tugba Akin Telli

|Jun 13, 2022
Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy.

Tugba Akin Telli, Mehmet Akif Ozturk, Ozkan Alan

|May 11, 2022
Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?

Özgecan Dülgar, Başak Bala Öven, Muhammed Mustafa Atcı

Pageof 2

Frequent Collaborators

6 joint publications

Tuğba Akın Telli

5 joint publications

Tuğba Başoğlu

5 joint publications

Özlem Ercelep

5 joint publications

Perran Fulden Yumuk